25
total announcements
544306.BO · 15 min delayed
Sai Life Sciences Ltd
Sai Life Sciences Ltd has announced its unaudited financial results for the quarter ended 30 June 2026, with a profit before exceptional items and tax of ₹953.34 crore and a profit for the period of ₹713.39 crore.
Sai Life Sciences Ltd
Sai Life Sciences Ltd has announced its unaudited financial results for the quarter ended 30 June 2026, with a profit before tax of Rs. 953.34 crore and a profit for the period of Rs. 713.39 crore.
Sai Life Sciences Ltd
Sai Life Sciences Ltd has scheduled an analyst/investor meet on August 13-14, 2026, in Singapore, as per SEBI regulations.
Sai Life Sciences Ltd
Sai Life Sciences Ltd is hosting an earnings conference call on August 7, 2026, to discuss its un-audited financial results for the quarter ended June 30, 2026.
Sai Life Sciences Ltd
Sai Life Sciences Ltd has allotted 1,70,501 fully paid-up equity shares upon the exercise of options granted under its Employees Stock Option Plan 2008 (5,002 shares) and Management ESOP Plan 2018 (1,65,499 shares). This allotment, approved by the Board of Directors on June 22, 2026, results in the total issued shares increasing to 21,22,86,016. The transaction involves a minor dilution of equity but also brings in capital from the exercise prices.